Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03516019 · ClinicalTrials.gov registry record · NA
eFHS Messaging Trial
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 650
- Enrollment target
NCT03516019: Completed NA study, sponsored by Boston University.
NCT03516019 is a NA study that has completed, run by Boston University. The registered enrollment target is 650 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03516019, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
Study Summary
In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device. The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.
Primary Outcome
proportion of participants who submit their weekly blood pressure measurement at 3 months
Interventions
- OTHER personalized notices
- OTHER standard notices
- OTHER am notices
- OTHER pm notices
- OTHER weekday notices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2018-05-19 |
| Est. Completion | 2019-03-23 |
| Phase | NA |
What the finished NCT03516019 record still lists
NCT03516019 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 5 interventions - of which personalized notices is the first listed.
NCT03516019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03516019 about?
NCT03516019 is a clinical study titled "eFHS Messaging Trial". In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHe...
What is the current status of trial NCT03516019?
This trial is currently completed. It is a NA study. The enrollment target is 650 participants. The study started on 2018-05-19. Estimated completion is 2019-03-23.
What interventions are being tested in trial NCT03516019?
The interventions under investigation include: personalized notices (OTHER), standard notices (OTHER), am notices (OTHER), pm notices (OTHER), weekday notices (OTHER).
Who is sponsoring clinical trial NCT03516019?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03516019's enrollment target sits among peer trials
650 156th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI